« Return to News | CROs/Service Providers

Novotech expands partnership with Medidata Solutions

Friday, May 31, 2013 10:26 AM

Novotech, an Australia-based CRO, has expanded its relationship with Medidata Solutions, a global provider of cloud-based clinical development solutions, by achieving accreditation for Medidata Rave, a system for electronic data capture (EDC) and clinical data management (CDM).

Novotech joined the Medidata Partner Program in 2010 to support its offering of data management solutions for biotechnology and pharmaceutical clients conducting phase I-III trials, and has since expanded its use of Medidata technology in its clinical trials, including Rave for data management and Medidata Balance for randomization services. Novotech takes advantage of Medidata’s cloud-based technology to streamline and enhance clinical processes for their clients.

Novotech CEO Alek Safarian said its Rave accreditation means Novotech clients can expect further streamlining of EDC delivery from the CRO, using a single data platform across complex regional studies.

 “With our partnership expansion, Novotech now combines their deep expertise and best practices for leveraging Medidata’s cloud-based technology to further benefit sponsors’ clinical trials,” said Steve Heath, vice president of channel sales at Medidata Solutions.

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.